Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Median Effective Dose of Rocuronium for the Prevention of Myofibrillation Caused by the Injection of Succinylcholine

NCT05909696 is registered in ClinicalTrials.gov with Yangzhou University as lead sponsor.

NCT NCT05909696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05909696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Median Effective Dose of Rocuronium for the Prevention of Myofibrillation Caused by the Injection of Succinylcholine
Lead sponsor
Yangzhou University
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2023
Completion date
October 31, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myofibrillation, succinylcholine